Jang S, et al. – The efficacy and adverse outcomes between uncovered self–expandable metallic stent (USEMSs) and covered SEMSs (CSEMSs) were compared. In the management of malignant bile duct stricture, CSEMSs and USEMSs had similar clinical success rates and patency durations. However, CSEMSs was correlated with increased rates of migration and cholecystitis. Comparable efficacy and superior safety profile of USEMSs rendered a compelling argument for its place as the preferred choice of the self–expandable metallic stent (SEMS) in the management of malignant biliary stricture.